Antisense Approaches for the Treatment of Cancer
- 1 January 2000
- journal article
- review article
- Published by Taylor & Francis in Cancer Investigation
- Vol. 18 (7) , 635-650
- https://doi.org/10.3109/07357900009032830
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- BCL-2 antisense therapy in patients with non-Hodgkin lymphomaThe Lancet, 1997
- Protein Kinase C-ζ Mediates Angiotensin II Activation of ERK1/2 in Vascular Smooth Muscle CellsPublished by Elsevier ,1997
- Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA-in vitro and in vivo studiesZeitschrift für Krebsforschung und Klinische Onkologie, 1997
- Antisense Oligonucleotides Demonstrate a Dominant Role of c-Ki-RAS Proteins in Regulating the Proliferation of Diploid Human FibroblastsPublished by Elsevier ,1996
- Progress in Antisense Oligonucleotide TherapeuticsAnnual Review of Pharmacology and Toxicology, 1996
- The ins and outs of Raf kinasesTrends in Biochemical Sciences, 1994
- Activation of the MAP kinase pathway by the protein kinase rafCell, 1992
- Viral myb oncogene encodes a sequence-specific DNA-binding activityNature, 1988
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Nucleotide Sequence Analysis of the T24 Human Bladder Carcinoma OncogeneScience, 1983